Analyst Ratings for Mednax (MD) [Buys]
MD Rating Summary
MD Price Target Summary
- Highest: $96.00 (Goldman Sachs)
- Lowest: $76.00 (Deutsche Bank)
- Average: $84.88
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$84.88 (-9%)
Avg. $ Target:
$84.88 (-9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/5/2012 | Stifel Nicolaus » Updated 9/20/2012 |
New Coverage | Buy (N/A) |
83.00 (74.00) |
60.20 | 93.25 | 54.9% | Details |
| 12/22/2011 | BB&T Capital | New Coverage | Buy (N/A) |
80.00 (N/A) |
68.53 | 93.25 | 36.07% | Details |
| 7/27/2011 | Morgan Keegan | Upgrade | Outperform (N/A) |
85.00 (N/A) |
70.50 | 93.25 | 32.27% | Details |
| 6/23/2011 | Piper Jaffray | New Coverage | Overweight (N/A) |
N/A (N/A) |
72.02 | 93.25 | 29.48% | Details |
| 5/4/2011 | Feltl & Co » Updated 9/20/2012 |
Downgrade | Buy (N/A) |
86.00 (79.00) |
72.48 | 93.25 | 28.66% | Details |
| 3/25/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
63.78 | 93.25 | 46.21% | Details |
| 2/18/2011 | Collins Stewart | New Coverage | Buy (N/A) |
N/A (N/A) |
64.95 | 93.25 | 43.57% | Details |
| 12/20/2010 | RBC Capital | New Coverage | Top Pick (N/A) |
N/A (N/A) |
67.19 | 93.25 | 38.79% | Details |
